Suppr超能文献

TIGIT A2Ar 依赖性抗葡萄膜炎调节性 T 细胞是与自身免疫性葡萄膜炎消退相关的调节性 T 细胞的一个新亚群。

TIGIT A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.

机构信息

Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

出版信息

J Autoimmun. 2020 Jul;111:102441. doi: 10.1016/j.jaut.2020.102441. Epub 2020 Mar 20.

Abstract

Regulatory T cells (Tregs) are necessary to prevent autoimmune disease. As such, stable FoxP3 expression is required for the proper function of Tregs in the control of autoimmune disease. Different Treg subsets that utilize different mechanisms of suppression have been identified. The T-cell immunoglobulin immunoreceptor tyrosine-based inhibitory motif (TIGIT) is a relatively new Treg cell marker that has a suppressive function. We have previously identified the adenosine 2A receptor (A2Ar) as a requirement for the emergence of Tregs following resolution of autoimmune disease. Using a FoxP3-GFP-Cre reporter mouse, we identify FoxP3 and 'exFoxP3' cells, show FoxP3 and not exFoxP3 cells are suppressive. We further show FoxP3 cells express TIGIT, and are induced through A2Ar in healthy volunteers, but not patients with autoimmune disease. Furthermore, we show Tregs emerge in the target tissue at the onset of autoimmune disease in an A2Ar-dependent manner. In summary, we identify a novel subset of TIGIT Tregs that are induced through stimulation of the A2Ar.

摘要

调节性 T 细胞(Tregs)对于预防自身免疫性疾病是必需的。因此,Tregs 在控制自身免疫性疾病中发挥适当功能需要稳定的 FoxP3 表达。已经鉴定出利用不同抑制机制的不同 Treg 亚群。T 细胞免疫球蛋白免疫受体酪氨酸基抑制基序(TIGIT)是一种相对较新的 Treg 细胞标志物,具有抑制功能。我们之前已经确定腺苷 2A 受体(A2Ar)是自身免疫性疾病缓解后 Tregs 出现的必需条件。使用 FoxP3-GFP-Cre 报告小鼠,我们鉴定出 FoxP3 和“exFoxP3”细胞,表明 FoxP3 而不是 exFoxP3 细胞具有抑制作用。我们进一步表明 FoxP3 细胞表达 TIGIT,并通过 A2Ar 在健康志愿者中诱导,但在自身免疫性疾病患者中没有诱导。此外,我们表明 Tregs 以 A2Ar 依赖性方式在自身免疫性疾病发作时出现在靶组织中。总之,我们鉴定出一种新型的通过刺激 A2Ar 诱导的 TIGIT Tregs 亚群。

相似文献

1
TIGIT A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.
J Autoimmun. 2020 Jul;111:102441. doi: 10.1016/j.jaut.2020.102441. Epub 2020 Mar 20.
2
A2Ar-dependent PD-1+ and TIGIT+ Treg cells have distinct homing requirements to suppress autoimmune uveitis in mice.
Mucosal Immunol. 2023 Aug;16(4):422-431. doi: 10.1016/j.mucimm.2023.04.005. Epub 2023 May 9.
4
Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.
J Immunol. 2015 Apr 1;194(7):3011-9. doi: 10.4049/jimmunol.1402650. Epub 2015 Feb 25.
6
Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs.
J Leukoc Biol. 2015 Jun;97(6):1101-9. doi: 10.1189/jlb.3A1014-466RR. Epub 2015 Apr 15.
9
Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.
J Immunol. 2013 Oct 15;191(8):4103-11. doi: 10.4049/jimmunol.1300182. Epub 2013 Sep 16.

引用本文的文献

1
CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis.
Sci Rep. 2025 May 22;15(1):17745. doi: 10.1038/s41598-025-02816-z.
2
Regulatory T Cells: Therapeutic Opportunities in Uveitis.
Front Ophthalmol (Lausanne). 2022 May 25;2:901144. doi: 10.3389/fopht.2022.901144. eCollection 2022.
3
TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration.
J Leukoc Biol. 2024 Nov 4;116(5):1054-1060. doi: 10.1093/jleuko/qiae116.
5
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.
Adv Drug Deliv Rev. 2023 Jul;198:114869. doi: 10.1016/j.addr.2023.114869. Epub 2023 May 10.
6
A2Ar-dependent PD-1+ and TIGIT+ Treg cells have distinct homing requirements to suppress autoimmune uveitis in mice.
Mucosal Immunol. 2023 Aug;16(4):422-431. doi: 10.1016/j.mucimm.2023.04.005. Epub 2023 May 9.
8
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment.
Front Oncol. 2023 Feb 17;13:1060112. doi: 10.3389/fonc.2023.1060112. eCollection 2023.
9
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy.
Front Immunol. 2022 Oct 25;13:1012927. doi: 10.3389/fimmu.2022.1012927. eCollection 2022.
10
TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.
Front Immunol. 2022 Jun 3;13:911919. doi: 10.3389/fimmu.2022.911919. eCollection 2022.

本文引用的文献

1
PD-1 melanocortin receptor dependent-Treg cells prevent autoimmune disease.
Sci Rep. 2019 Nov 15;9(1):16941. doi: 10.1038/s41598-019-53297-w.
2
Exacerbation of autoimmune uveitis by obesity occurs through the melanocortin 5 receptor.
J Leukoc Biol. 2019 Oct;106(4):879-887. doi: 10.1002/JLB.MA0119-030RR. Epub 2019 Jul 9.
4
Mechanisms of human FoxP3 T cell development and function in health and disease.
Clin Exp Immunol. 2019 Jul;197(1):36-51. doi: 10.1111/cei.13290. Epub 2019 Apr 1.
5
Microenvironment tailors nTreg structure and function.
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6298-6307. doi: 10.1073/pnas.1812471116. Epub 2019 Mar 7.
6
Human FOXP3 Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.
Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020.
7
Regulatory T cells in autoimmune disease.
Nat Immunol. 2018 Jul;19(7):665-673. doi: 10.1038/s41590-018-0120-4. Epub 2018 Jun 20.
8
Emerging Functions of Regulatory T Cells in Tissue Homeostasis.
Front Immunol. 2018 Apr 25;9:883. doi: 10.3389/fimmu.2018.00883. eCollection 2018.
10
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.
Immunity. 2016 May 17;44(5):989-1004. doi: 10.1016/j.immuni.2016.05.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验